- Home
- CLRB vs AMST Comparison
CLRB vs AMST Comparison
Compare CLRB & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- AMST
- Stock Information
- Founded
- CLRB 2002
- AMST 2017
- Country
- CLRB United States
- AMST United States
- Employees
- CLRB N/A
- AMST N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- CLRB Health Care
- AMST Technology
- Exchange
- CLRB Nasdaq
- AMST Nasdaq
- Market Cap
- CLRB 14.2M
- AMST 15.7M
- IPO Year
- CLRB N/A
- AMST 2020
- Fundamental
- Price
- CLRB $5.49
- AMST $3.22
- Analyst Decision
- CLRB Hold
- AMST
- Analyst Count
- CLRB 2
- AMST 0
- Target Price
- CLRB N/A
- AMST N/A
- AVG Volume (30 Days)
- CLRB 89.6K
- AMST 2.1M
- Earning Date
- CLRB 11-17-2025
- AMST 11-13-2025
- Dividend Yield
- CLRB N/A
- AMST N/A
- EPS Growth
- CLRB N/A
- AMST N/A
- EPS
- CLRB N/A
- AMST N/A
- Revenue
- CLRB N/A
- AMST $82,544.00
- Revenue This Year
- CLRB N/A
- AMST N/A
- Revenue Next Year
- CLRB N/A
- AMST N/A
- P/E Ratio
- CLRB N/A
- AMST N/A
- Revenue Growth
- CLRB N/A
- AMST N/A
- 52 Week Low
- CLRB $4.11
- AMST $2.00
- 52 Week High
- CLRB $67.50
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- CLRB 60.03
- AMST 55.32
- Support Level
- CLRB $5.05
- AMST $3.11
- Resistance Level
- CLRB $5.34
- AMST $3.56
- Average True Range (ATR)
- CLRB 0.34
- AMST 0.29
- MACD
- CLRB 0.07
- AMST 0.06
- Stochastic Oscillator
- CLRB 98.15
- AMST 28.44
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.